131
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Epstein-Barr virus associated colitis in kidney transplant patients: a case series

, , , , , & show all
Pages 410-415 | Received 11 Oct 2023, Accepted 27 Feb 2024, Published online: 09 Mar 2024

References

  • Pullerits K, Garland S, Rengarajan S, et al. Kidney transplant-associated viral infection rates and outcomes in a Single-Centre cohort. Viruses. 2022;14(11):2406. doi: 10.3390/v14112406.
  • Blazquez-Navarro A, Dang-Heine C, Wehler P, et al. Risk factors for epstein–barr virus reactivation after renal transplantation: results of a large, multi-Centre study. Transpl Int. 2021;34(9):1680–1688. doi: 10.1111/tri.13982.
  • Le J, Durand CM, Agha I, et al. Epstein–barr virus and renal transplantation. Transplant. Rev. W.B. Saunders. 2017;31(1):55–60. doi: 10.1016/j.trre.2016.12.001.
  • Shen Y, Wang YF. Chronic active epstein–barr virus enteritis: a literature review. J of Digest Diseases. 2022;23(5-6):248–252. doi: 10.1111/1751-2980.13097.
  • Grupper A, Schwartz D, Baruch R, et al. Kidney transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity. Transpl Int. 2019;32(7):730–738. doi: 10.1111/tri.13415.
  • Zhang H, Zhao S, Cao Z. Impact of epstein–barr virus infection in patients with inflammatory bowel disease. Front Immunol. 2022;13:1001055. doi: 10.3389/fimmu.2022.1001055.
  • Xu W, Jiang X, Chen J, et al. Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease. BMC Gastroenterol. 2020;20:257. doi: 10.1186/s12876-020-01395-9.
  • Oki R, Hidaka S, Sasaki A, et al. De novo ulcerative colitis after kidney transplantation treated with infliximab. CEN Case Rep. 2021;10(4):500–505. doi: 10.1007/s13730-021-00599-6.
  • Gioco R, Puzzo L, Patanè M, et al. Post-transplant colitis after kidney transplantation: clinical, endoscopic and histological features. Aging. 2020;12(24):24709–24720. doi: 10.18632/aging.202345.
  • Núñez Ortiz A, Rojas Feria M, de la Cruz Ramírez MD, et al. Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes. Rev Esp Enferm Dig. 2022;114(5):259–265. doi: 10.17235/reed.2021.7915/2021.
  • Abbas A, Zimmer AJ, Florescu D. Viral enteritis in solid-organ transplantation. Viruses. 2021;13(10):2019. doi: 10.3390/v13102019.
  • Gioco R, Corona D, Ekser B, et al. Gastrointestinal complications after kidney transplantation. WJG. 2020;26(38):5797–5811. https://www.wjgnet.com/bpg/gerinfo/240 doi: 10.3748/wjg.v26.i38.5797.
  • Murata T, Sugimoto A, Inagaki T, et al. Molecular basis of epstein–barr virus latency establishment and lytic reactivation. Viruses. 2021;13(12):2344. doi: 10.3390/v13122344.
  • Fan H, Gulley ML. Molecular methods for detecting Epstein-Barr virus (Part I): in situ hybridization to Epstein-Barr virus-encoded RNA (EBER) transcripts. Methods Mol Med. 2001;49:301–311. doi: 10.1385/1-59259-081-0:301.
  • Ylinen E, Merras-Salmio L, Jahnukainen T. Gastrointestinal symptoms and endoscopy findings after pediatric solid organ transplantation: a case series. Pediatr Transplant. 2022;26(7):e14374. doi: 10.1111/petr.14374.
  • Walti LN, Mugglin C, Sidler D, et al. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): a nationwide cohort study. Am. J. Transplant. 2021;21(7):2532–2542. doi: 10.1111/ajt.16423.
  • Lv K, Yin T, Yu M, et al. Treatment advances in EBV related lymphoproliferative diseases. Front Oncol. 2022;12:838817. doi: 10.3389/fonc.2022.838817.
  • Keam SJ. Tabelecleucel: first approval. Mol Diagn Ther. 2023;27(3):425–431. doi: 10.1007/s40291-023-00648-z.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.